Across TCGA pan-cancer cohorts, RPS3AP30 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS3AP30’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS3AP30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS3AP30 is over-expressed in tumor.

STAD and LIHC are the cancer types where RPS3AP30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS3AP30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	All	+0.185	.008	4	view →
LIHC	All	All	+0.007	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPS3AP30 RNA expression & survival · all RPS3AP30 data types